Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NEDERGAARD BIO ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3%   Bankruptcy risk   2.9% 4.2% 3.2% 4.1% 4.5% 3.6% 10.8% 10.6%   Credit score (0-100)   60 49 55 47 46 51 23 23   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   178 597 1,096 513 73.0 42.6 0.0 0.0   EBITDA   178 121 346 69.4 78.1 38.6 0.0 0.0   EBIT   109 52.8 329 52.4 75.7 38.6 0.0 0.0   Pre-tax profit (PTP)   9.9 33.0 311.8 39.9 308.1 276.1 0.0 0.0   Net earnings   7.8 25.4 243.2 31.1 256.1 235.2 0.0 0.0   Pre-tax profit without non-rec. items   9.9 33.0 312 39.9 308 276 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   103 34.0 17.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   309 334 577 608 865 1,100 975 975   Interest-bearing liabilities   364 122 264 169 873 2,212 0.0 0.0   Balance sheet total (assets)   4,254 4,736 4,557 4,918 5,134 4,861 975 975   Net Debt   364 122 264 169 873 2,212 -975 -975     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   178 597 1,096 513 73.0 42.6 0.0 0.0   Gross profit growth   -67.5% 236.1% 83.6% -53.2% -85.8% -41.6% -100.0% 0.0%   Employees   0 2 3 2 0 0 0 0   Employee growth %   0.0% 0.0% 50.0% -33.3% -100.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,254 4,736 4,557 4,918 5,134 4,861 975 975   Balance sheet change%   -14.8% 11.3% -3.8% 7.9% 4.4% -5.3% -79.9% 0.0%   Added value   177.6 121.5 345.8 69.4 92.7 38.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -137 -137 -34 -34 -5 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   61.3% 8.8% 30.0% 10.2% 103.7% 90.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   2.4% 1.2% 7.1% 1.1% 6.3% 6.8% 0.0% 0.0%   ROI %   6.4% 9.3% 47.7% 5.9% 23.1% 12.6% 0.0% 0.0%   ROE %   2.5% 7.9% 53.4% 5.3% 34.8% 23.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   7.3% 7.1% 12.7% 12.4% 16.8% 22.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   205.0% 100.8% 76.5% 242.9% 1,118.0% 5,726.8% 0.0% 0.0%   Gearing %   117.9% 36.7% 45.8% 27.7% 101.0% 201.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.2% 8.2% 8.8% 5.8% 1.5% 4.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.2 0.1 0.2 0.3 0.2 0.0 0.0   Current Ratio   0.0 0.2 0.1 0.2 0.3 0.2 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -3,796.3 -3,696.1 -3,368.2 -3,311.3 -3,000.9 -2,729.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 61 115 35 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 61 115 35 0 0 0 0   EBIT / employee   0 26 110 26 0 0 0 0   Net earnings / employee   0 13 81 16 0 0 0 0